iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s stock price dropped 0.5% on Monday . The stock traded as low as $33.80 and last traded at $33.99. Approximately 556 shares traded hands during mid-day trading, a decline of 69% from the average daily volume of 1,783 shares. The stock had previously closed at $34.15.
iShares Neuroscience and Healthcare ETF Stock Down 0.5%
The firm has a market cap of $5.10 million, a PE ratio of 15.61 and a beta of 0.77. The company’s fifty day moving average price is $34.47 and its two-hundred day moving average price is $32.83.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
